Medican Enterprises logo

Medican Enterprises(OTC) MDCN

Market Cap$46.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1991)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Medican Enterprises last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-15
Medican Enterprises stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-04
1 month+0%USD 0.002026-08-13
3 month+0%USD 0.002026-06-17
Year to date+0%USD 0.002025-12-31
1 year+0%USD 0.002025-09-15
3 year+0%USD 0.002023-09-13
5 year-99.75%USD 0.002021-09-16
Since inception-100%USD 5.181991-09-16

Medican Enterprises Financials at a Glance

Market Cap

$46.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.60M

Net Income (TTM)

$4.65M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-28.74 (Low)

Price

$0.00

Volume

2,275,499

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

MDCN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medican Enterprises

Medican Enterprises, Inc. is a company focused on investments in sports and entertainment, particularly in basketball franchises and digital media assets. The organization also engages in the management and development of basketball teams, media content production, and the creation of digital collectibles.

Products and Services
  • Ownership stakes in basketball franchises
  • Production and licensing of sports-related media content
  • Creation and management of non-fungible tokens (NFTs)
Growth Outlook
  • Recent quarterly revenue reached 936,872, indicating potential for growth
  • Positive operating income of 789,425 in the latest quarter
  • Strategic investments in digital assets align with market trends
Financial Highlights
  • Trailing twelve months (TTM) revenue of 936,872 shows upward momentum
  • Net income of 789,425 in the latest quarter reflects operational efficiency
  • Market capitalization stands at approximately 2.88 million, indicating growth potential
Medican Enterprises, Inc. operates within the medical and pharmaceutical industry, leveraging opportunities in sports and entertainment. The company has shown resilience with a recent quarterly revenue of 936,872, marking a significant increase compared to previous periods. The positive operating income of 789,425 suggests effective management and operational strategies. With a market capitalization of approximately 2.88 million, Medican Enterprises, Inc. is positioned to capitalize on emerging trends in digital assets and sports investments. The focus on NFTs and digital media aligns with the growing interest in these sectors, potentially enhancing future growth prospects.
AI Generated • Aug 28, 2026

Industry

Pharmaceuticals

CEO

Mitchell Xavier

Headquarters

Woodland Hills, CA 91367, US

MDCN Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-5.20%

Return on Capital

-4.15%

Return on Assets

-2.51%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$46.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

46.55B

Volume

2.28M

Avg. Volume

487.61K

Financials (TTM)

Gross Profit

$342.33K

Operating Income

-$927.10K

EBITDA

$1.65M

Operating Cash Flow

-$9.39M

Capital Expenditure

-$5.00

Free Cash Flow

-$9.39M

Cash & ST Invst.

$75.30K

Total Debt

$19.82M

Medican Enterprises Performance Analysis

Medican Enterprises annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 4,239,220N/A
20222022-12-31USD 2,608,851-38.5%
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
Medican Enterprises sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32022-09-30-23.6%
Q22024-06-30N/A
Q42024-12-31N/A
Q12025-03-31N/A
Medican Enterprises annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.00N/A
20222022-12-31USD 0.00N/A
20232023-12-31USD 0.00N/A
20242024-12-31USD 0.00N/A
Medican Enterprises sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32022-09-304899.5%
Q22024-06-30N/A
Q42024-12-31N/A
Q12025-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$936.87K

+7.7%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$46.50KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$15.50K

N/A

Employees

3

N/A

Net Income

$789.43K

+913.4%

EBITDA

$789.43K

+400.0%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Total Cash

$75.30K

-74.1%

Total Debt

$19.82M

-22.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$19.82M

-22.8%

Short Term Debt

$0.00

N/A

Return on Assets

-2.51%

N/A

Return on Invested Capital

-4.15%

N/A

Free Cash Flow

-$19.35M

-28040.3%

Operating Cash Flow

-$19.35M

-28040.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CRDVCommunity Redevelopment Inc.
$0.00+0.00%
CDJMCarnegie Development, Inc.
$0.00+0.00%
BRSTBroad Street Realty, Inc.
$0.00+0.00%
ENTIEncounter Development Technologies Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MEDSDataMEDS Ai
$6.07+274.69%
AALAmerican Airlines Group
$12.70-0.55%
NOKNokia
$10.14+3.05%
INTCIntel
$101.05+4.03%

Questions About MDCN

What is the current price of Medican Enterprises?

Medican Enterprises is trading at $0.00 per share.

What is the 52-week range for Medican Enterprises?

Over the past 52 weeks, Medican Enterprises has traded between $0.00 and $0.00.

How much debt does Medican Enterprises have?

As of the most recent reporting period, Medican Enterprises reported total debt of $16.48M.

How much cash does Medican Enterprises have on hand?

Medican Enterprises reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Medican Enterprises’s dividend yield?

Medican Enterprises does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.